Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pattern Scan Laser improves Retinal Treatment Outcomes

By HospiMedica staff writers
Posted on 19 Feb 2008
An innovative laser system has been designed for the treatment of retinal diseases such as proliferative diabetic retinopathy, choroidal neovascularization, age-related macular degeneration, and retinal tears and detachments.

The PASCAL (Pattern Scan Laser) photocoagulator is intended for use in the treatment of ocular pathology, and is indicated for use in photocoagulation of both posterior and anterior segments including panretinal, focal, and macular grid photocoagulation. More...
The technology platform is based upon the use of a proprietary, semi-automated, pattern generation method employing short 532-nanometer laser pulses. This method of photocoagulation allows delivery of a predetermined pattern by scanning the placement of the laser spots and controlling the emission of the laser light. Up to five predetermined pattern types can be selected, including square arrays for panretinal photocoagulation; triple arcs for retinal tears, lattice degeneration and panretinal photocoagulation; and focal, full, and modified macular grids. The laser pulses are delivered in a rapid predetermined sequence resulting in improved precision, safety, patient comfort, and a significant reduction in treatment time compared with single-spot photocoagulation.

The fully integrated system incorporates an intuitive touch screen user interface, pattern scanner technology, an advanced optics slit lamp with a mounted micromanipulator, dual slit lamp mounted rotary power controls, proprietary PrecisionSpot laser delivery, a wheelchair accessible table, and other ergonomic features for both the physician and patient. The PASCAL photocoagulator is a product of OptiMedica (Santa Clara, CA, USA) and the winner of a gold medal at the 2007 Medical Design Excellence Awards.

Pre-clinical animal studies, as well as initial pilot studies in humans indicate that in addition to reducing treatment duration for typical patients with proliferative diabetic retinopathy, the number of sessions may also be reduced.


Related Links:
OptiMedica

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.